The Chief Medical Officer (CMO) for England, working with the Chief Medical Officers of the devolved nations and other senior clinicians, commissioned us to produce a list of people at ‘high risk’ of complications from COVID-19. These people either have or will be advised to consider shielding for at least 12 weeks. This list is referred to as the Shielded Patient List.
A new alert has been made available for the people on the Shielded Patient List through the SCRa, and the SCRa private beta following a pilot with community pharmacies and the London Ambulance Service.
The alert states ‘This person has been advised to consider shielding. This information may support you to manage this patient but should not be used in isolation as an assessment of risk. Patient management decisions should always be made drawing on the widest range of information sources.’ The list of people for whom this alert is set is held within the NHS Spine and is updated weekly.
This alert along with healthcare information from other sources, such as a patient’s letter saying they are on the shielded patient list, will support healthcare professionals to decide how they provide services to these people during the pandemic.